Area of research
Immunology · Oncology
Research interest
Research interests include Medicine, Internal medicine, Adverse effect, Melanoma, Cancer, and Sarcopenia.
Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Genomic and Proteomic Profiling Reveals Reduced Mitochondrial Function and Disruption of the Neuromuscular Junction Driving Rat Sarcopenia